This Top Growth Stock to Buy in March Fell 6% This Week, but Is Up More Than 200% in Just 3 Years

The company combines a hyper-efficient automated platform with massive account growth to justify the stock's premium valuation.

Forget Tilray: This Cash‑Flow Monster Can Outlast Every Cannabis Hype Cycle

Tilray Brands is losing money as it attempts to build a consumer staples business, while this industry giant throws off tons of cash.